×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMRX – immuneering corporation - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
06:20 pm
imrx
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $13.00 price target on the stock.
Medium
Report
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $13.00 price target on the stock.
11/14
08:15 am
imrx
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
Low
Report
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
11/13
04:05 pm
imrx
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
High
Report
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
10/15
09:05 am
imrx
Immuneering rises on orphan drug designation for treatment of pancreatic cancer [Seeking Alpha]
Medium
Report
Immuneering rises on orphan drug designation for treatment of pancreatic cancer [Seeking Alpha]
10/15
08:00 am
imrx
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
High
Report
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
10/14
09:44 am
imrx
Here's Why We're A Bit Worried About Immuneering's (NASDAQ:IMRX) Cash Burn Situation [Yahoo! Finance]
Medium
Report
Here's Why We're A Bit Worried About Immuneering's (NASDAQ:IMRX) Cash Burn Situation [Yahoo! Finance]
9/16
11:29 am
imrx
IMRX Stock Soars on Upbeat Efficacy Data From Pancreatic Cancer Study [Yahoo! Finance]
High
Report
IMRX Stock Soars on Upbeat Efficacy Data From Pancreatic Cancer Study [Yahoo! Finance]
9/13
08:23 am
imrx
Why Is Nanocap Immuneering Stock Trading Higher On Friday? [Yahoo! Finance]
Low
Report
Why Is Nanocap Immuneering Stock Trading Higher On Friday? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2024
04:05 pm
imrx
immuneering corporation - class a
BEAT
Report
12.1%
immuneering corporation - class a
8/6/2024
04:05 pm
imrx
immuneering corporation - class a
BEAT
Report
-8.1%
immuneering corporation - class a
5/7/2024
04:05 pm
imrx
immuneering corporation - class a
MISS
Report
4.5%
immuneering corporation - class a
3/1/2024
08:00 am
imrx
immuneering corporation - class a
MISS
Report
-0.8%
immuneering corporation - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:16 pm
imrx
Form SC 13G/A Immuneering Corp Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SC 13G/A Immuneering Corp Filed by: CITADEL ADVISORS LLC
11/14
03:04 pm
imrx
Form SC 13G/A Immuneering Corp Filed by: Cormorant Asset Management, LP
Low
Report
Form SC 13G/A Immuneering Corp Filed by: Cormorant Asset Management, LP
11/13
04:10 pm
imrx
Form 10-Q Immuneering Corp For: Sep 30
High
Report
Form 10-Q Immuneering Corp For: Sep 30
11/13
04:04 pm
imrx
Form 8-K Immuneering Corp For: Nov 13
High
Report
Form 8-K Immuneering Corp For: Nov 13
10/2
04:11 pm
imrx
Form 8-K/A Immuneering Corp For: Mar 11
Medium
Report
Form 8-K/A Immuneering Corp For: Mar 11
9/17
04:09 pm
imrx
Form 4 Immuneering Corp For: Sep 15 Filed by: Morales Mallory
High
Report
Form 4 Immuneering Corp For: Sep 15 Filed by: Morales Mallory
9/12
04:11 pm
imrx
Form 8-K Immuneering Corp For: Sep 12
Medium
Report
Form 8-K Immuneering Corp For: Sep 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: